RTID-11. GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

Developing new therapies for patients with glioblastoma (GBM) requires focused interaction between industry, academia, nonprofits, patient advocacy, and health authorities, and novel approaches to clinical trials. GBM Adaptive Global Innovative Learning Environment (GBM AGILE) Trial was designed by...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Buxton, Meredith, Alexander, Brian, Berry, Donald, Cavenee, Webster, Colman, Howard, de Groot, John, Ellingson, Benjamin, Gordon, Gary, Khasraw, Mustafa, Lassman, Andrew, Lee, Wenbin, Lim, Michael, Mellinghoff, Ingo, Perry, James, Sulman, Erik, Tanner, Kirk, Weller, Michael, Wen, Patrick, Yung, W K Alfred, Cloughesy, Timothy, Investigators, G B M Agile
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Randomized Trials in Development
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651338/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.816
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi